Advertisement

Biotechnology Letters

, Volume 22, Issue 2, pp 123–128 | Cite as

Production of the antibiotic gallidermin by Staphylococcus gallinarum – development of a scale-up procedure

  • M. Kempf
  • U. Theobald
  • H.-P. Fiedler
Article

Abstract

A scale-up strategy into 200 l pilot-scale for the production of the antibiotic gallidermin by Staphylococcus gallinarum Tü 3928 was developed. Large-scale fermentations were simulated by consecutive liquid cultures of smaller scale. Afterwards, optimised cultivation conditions were transferred to pilot-scale. Best results were achieved by addition of Maltose during the late production phase leading to a final concentration of 330 mg gallidermin per litre. Compared to the concentrations found in a non-pulsed pilot-scale fermentations this is an increase of 20–30%.

antibiotic gallidermin production scale-up procedure Staphylococcus gallinarum 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clark GJ, Langley D, Bushell ME (1995) Oxygen limitation can induce microbial secondary metabolite formation: investigations with miniature electrodes in shaker and bioreactor culture. Microbiology 141: 663–669.Google Scholar
  2. Hörner T, Ungermann V, Zähner H, Fiedler H-P, Utz R, Kellner R, Jung G (1990) Comparative studies on the fermentative production of lantibiotics by staphylococci. Appl. Microbiol. Biotechnol. 32: 511–517.Google Scholar
  3. Hosobuchi M, Yoshikawa H (1999) Scale-up of microbial processes. In: Demain AL, Davies JE, eds. Manual of Industrial Microbiology and Biotechnology, 2nd edn. Washington: ASM Press, pp. 236–239.Google Scholar
  4. Humphrey A (1998) Shake flask to fermentor: what have we learned? Biotechnol. Prog. 14: 3–7.Google Scholar
  5. Ju L-K, Chase GG (1992) Improved scale-up strategies of bioreactors. Bioprocess Eng. 8: 49–53.Google Scholar
  6. Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, Götz F (1988) Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177: 53–59.Google Scholar
  7. Kempf M, Theobald U, Fiedler H-P (1997) Influence of dissolved O2 on the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 19: 1063–1065.Google Scholar
  8. Kempf M, Theobald U, Fiedler H-P (1999a) Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 21: 663–667.Google Scholar
  9. Kempf M, Theobald U, Fiedler H-P (1999b) Correlation between the consumption of amino acids and the production of the antibiotic gallidermin by Staphylococcus gallinarum. Biotechnol. Lett. 21: 959–963.Google Scholar
  10. Reuss M, Bajpai R (1991) Stirred tank models. In: Rehm H-J and Reed G, eds. Biotechnology, Vol. 4, 2nd edn. Weinheim: VCH, pp. 299–348.Google Scholar
  11. Theobald U, Kempf M (1998) A novel tool for medium optimisation and characterization in the early stages of a metabolite production process. Biotechnol. Tech. 12: 893–897.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • M. Kempf
    • 1
  • U. Theobald
    • 1
  • H.-P. Fiedler
    • 1
  1. 1.Mikrobiologisches InstitutUniversität TübingenTübingenGermany

Personalised recommendations